Replies to post #461056 on Anavex Life Sciences Corp (AVXL)

[Hosai]

The 20th Nov PR refers to "meetings", presumably these had happened before Nov 20th unless they had multiple all on the day of the pr -

"NEW YORK – November 20, 2023

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders announced today that representatives of Anavex met with team members of the European Medicines Agency (EMA).

These meetings discussed the debilitating pathology of Alzheimer’s disease and Anavex’s blarcamesine (ANAVEX®2-73) Alzheimer’s disease clinical program results, including data obtained in the ANAVEX®2-73-AD-004 study.

Pursuant to the discussion at the meetings, Anavex initiated the process for submitting a Marketing Authorisation application to the EMA with the submission of the Centralised Procedure request with the goal of the Authorisation allowing direct access to the market of the European Union for oral blarcamesine for the treatment of Alzheimer’s disease."

[kund]

Is there any evidence that these EMA meetings have happened? Is FDA participating?

No meeting has happened, TGD lied about it, come 2030 he will be telling same thing. Why would FDA participate? Are you new to biotech?